[go: up one dir, main page]

HK1117037B - 改进释放1-[(3-羟基-金刚烷-1-基氨基)-乙酰基]-吡咯烷-2-(s)-腈的制剂 - Google Patents

改进释放1-[(3-羟基-金刚烷-1-基氨基)-乙酰基]-吡咯烷-2-(s)-腈的制剂 Download PDF

Info

Publication number
HK1117037B
HK1117037B HK08107114.8A HK08107114A HK1117037B HK 1117037 B HK1117037 B HK 1117037B HK 08107114 A HK08107114 A HK 08107114A HK 1117037 B HK1117037 B HK 1117037B
Authority
HK
Hong Kong
Prior art keywords
dosage form
day
vildagliptin
patient
pharmaceutically acceptable
Prior art date
Application number
HK08107114.8A
Other languages
German (de)
English (en)
French (fr)
Other versions
HK1117037A1 (zh
Inventor
James Kowalski
Jay Parthiban Lakshman
Abu T. M. Serajuddin
Yatindra Joshi
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Priority claimed from PCT/US2006/022416 external-priority patent/WO2006135723A2/en
Publication of HK1117037A1 publication Critical patent/HK1117037A1/zh
Publication of HK1117037B publication Critical patent/HK1117037B/zh

Links

HK08107114.8A 2005-06-10 2006-06-08 改进释放1-[(3-羟基-金刚烷-1-基氨基)-乙酰基]-吡咯烷-2-(s)-腈的制剂 HK1117037B (zh)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US68971905P 2005-06-10 2005-06-10
US60/689,719 2005-06-10
US69030905P 2005-06-14 2005-06-14
US60/690,309 2005-06-14
PCT/US2006/022416 WO2006135723A2 (en) 2005-06-10 2006-06-08 Modified release 1-[(3-hydroxy-adamant-1-ylamino)-acetyl]-pyrrolidine-2(s)-carbonitrile formulation

Publications (2)

Publication Number Publication Date
HK1117037A1 HK1117037A1 (zh) 2009-01-09
HK1117037B true HK1117037B (zh) 2010-04-23

Family

ID=

Similar Documents

Publication Publication Date Title
EP1898904B1 (en) Modified release 1-[(3-hydroxy-adamant-1-ylamino)-acetyl]-pyrrolidine-2(s)-carbonitrile formulation
CN101277688B (zh) 包含甲福明和维达列汀的配制物
KR20120104523A (ko) 디펩티딜 펩티다제―４ 억제제와 피오글리타존의 조합물의 제약 조성물
CN101208085B (zh) 1-[(3-羟基-金刚烷基-1-基氨基)-乙酰基]-吡咯烷基-2(s)-腈的调释制剂
HK1117037B (zh) 改进释放1-[(3-羟基-金刚烷-1-基氨基)-乙酰基]-吡咯烷-2-(s)-腈的制剂
HK1143094B (zh) 1-[(3-羟基-金刚烷-1-基氨基)-乙酰基]-吡咯烷-2(s)-甲腈制剂的调释
CN102349906B (zh) 阿托伐他汀钙和烟酸组合物及其制备方法
Gaffar Formulation and evaluation of bilayer tablets of lisinopril and gliclazide
Nagasaisandhya et al. Development and Charecterisation of Ramipril as Immediate Release and Metformin Hydrochloride as Sustained Release Bilayered Tablets
HK1121372B (zh) 包含二甲双胍和维格列汀的制剂